D'importants progrès sur la voie de l’élimination du paludisme sont enregistrés

De nouvelles estimations publiées par l’OMS montrent une augmentation importante du nombre de pays désormais sur la voie de l’élimination du paludisme.


Sanofi lance son vaccin contre la dengue

Enfin une bonne nouvelle pour Sanofi. Embarrassé depuis des mois par les contre-performances de sa division diabète, le groupe pharmaceutique tricolore a annoncé, mercredi 9 décembre, avoir reçu le feu vert des autorités mexicaines pour commercialiser son vaccin contre la dengue, une maladie tropicale transmise par les moustiques.

Men's self-image puts them in danger of dying from AIDS, research shows

Men's self-image as strong, sexually active risk-takers means they are more likely to die from HIV/AIDS than are women, experts said on Wednesday, calling for more HIV workplace testing to reach men and greater efforts to change gender norms.
Although six out of ten Africans with HIV are women, men are 25 percent more likely to die from the disease, according to research by the Africa Centre for Health and Population Studies in South Africa, which has the world's biggest AIDS epidemic.

Zimbabwe children still at great risk of HIV/AIDS, new data shows

BULAWAYO, Zimbabwe (Thomson Reuters Foundation) - Janet Dube knows the pain of raising a child born with HIV.
Her four-year-old son is one of an estimated 170,000 children living with HIV/AIDS in Zimbabwe, and figures released by the country's statistics agency on Wednesday showed the virus is the leading cause of death among children under five.
A Census Analysis Mortality Report from 1992-2012 revealed that despite progress in fighting the virus, HIV and AIDS had claimed the lives of thousands of Zimbabwean children under five.

Nigeria: FG, UNAIDS to Partner On Domestic HIV/Aids Drugs Manufacture, Others

The United Nations AIDS (UNAIDS) programme in Nigeria said it would partner the Federal Government in domestically sourcing funds and drugs for the control of HIV/AIDS in the country.
The Country Director of UNAIDS, Dr Bilali Camara, made this known to State House correspondents after paying a courtesy visit to Vice President Yemi Osinbajo at the Presidential Villa.

New report signals ‘significant progress’ towards malaria elimination – UN health agency

The world is making “significant progress” toward malaria elimination with prevention and treatment efforts saving more than 660 million lives and $900 million in case management costs since 2001, the World Health Organization (WHO) has reported.
According to the World Malaria Report 2015, released today, more than half (57) of the 106 countries with malaria in 2000 had achieved reductions in new malaria cases of at least 75 per cent by 2015. In that same time frame, 18 countries reduced their malaria cases by 50-75 per cent.

Fresh Ebola Cases Damp Liberia Hopes of Eliminating Deadly Disease

Nurses at a downtown Monrovia hospital were about to punch out from work late one November afternoon when a feverish teenager, convulsing and bleeding from his mouth, stumbled into the waiting room.
For Mosoka Fallah, the boy’s symptoms pointed in a grimly familiar direction. He drove off—speeding in the wrong lane and dodging head-on traffic—to a meeting of government officials in the center of the capital, where he burst into the room with the news: Ebola is back.

First Dengue Fever Vaccine Approved by Mexico

A dengue fever vaccine developed by the French pharmaceutical giant Sanofi has been approved for use by Mexico, the first approval in the world for any vaccine for the disease, which afflicts tens of millions of people around the world and is becoming an increasing threat.
Sanofi said in a news release Wednesday that the vaccine, which it is calling Dengvaxia, was approved by Mexico’s Federal Commission for the Protection against Sanitary Risk for prevention of dengue in people 9 to 45 years old living in endemic areas.

Sanofi wins first dengue vaccine market approval in Mexico

Sanofi's dengue vaccine is to make its market debut in Mexico, the French drugmaker said on Wednesday, adding that it expects to have filed for market approval in some 20 countries by year-end.
Sanofi Pasteur, the group's vaccines division, said Mexico had approved the preventive treatment, called Dengvaxia, for all four dengue virus serotypes, but only for patients aged 9 to 45 who live in areas where the disease is endemic.

Middle East respiratory syndrome coronavirus (MERS-CoV) – Saudi Arabia

Between 2 and 27 November 2015, the National IHR Focal Point for the Kingdom of Saudi Arabia notified WHO of 3 additional cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infectio